psychopharmacology | cpnp.org

Home
About CPNP
- Why Join CPNP
- Board of Directors
- Past Presidents
- Committees & Task Forces
- Awards
- CPNP Foundation
- Corporate Sponsorships
  - Sponsor Program
  - Sponsors
- Information for Patients
- Contact CPNP
Education
- April 2013 Annual Meeting in Colorado Springs, CO
- April 2014 Annual Meeting in Phoenix, AZ
- CPNP University Online Courses
- Drug-Induced Movement Disorders Training DVD
- Psychiatric Pharmacotherapy for Nurses
- Other Meetings
- Find More Resources in My CPNP
  - My CPNP Presentations & Exams
  - My CPNP ACPE Transcript Center
BCPP
- BCPP Exam Preparation
  - BCPP Exam Preparation
  - Certification FAQ
- BCPP Recertification
Careers/Residencies
Member Center
- Member Toolkit
- Email List
- Member Directory
- CPNP Documents and Reports
- Member Hubs
  - Pharmacy Student Hub
  - New Practitioner Hub
Resources
Gov't and Prof Affairs
- Comprehensive Medication Management
- Government Affairs
  - Contacting Legislators and Policy Makers
  - Medicare Coverage Initiative with ACCP
- Position/White Papers
  - Psychiatric Pharmacy Manifesto
  - Psychiatric Pharmacist Integration into the Medical Home Model
My CPNP
- Edit My Profile
- My Disclosures of Interest
- My Workspaces
- My Presentations & Exams
- My Volunteer Profile
- My CPNP Transcript Center
- My Opportunities

psychopharmacology

Characterizing the effects of Eugenol on neuronal ionic currents and hyperexcitability.

Huang C-W, Chow JC, Tsai J-J, Wu S-N. Characterizing the effects of Eugenol on neuronal ionic currents and hyperexcitability. Psychopharmacology (Berl). 2012;221(4):575-87. doi:10.1007/s00213-011-2603-y.

Suppression of endogenous PPARγ increases vulnerability to methamphetamine-induced injury in mouse nigrostriatal dopaminergic pathway.

Yu S-J, Airavaara M, Shen H, et al. Suppression of endogenous PPARγ increases vulnerability to methamphetamine-induced injury in mouse nigrostriatal dopaminergic pathway. Psychopharmacology (Berl). 2012;221(3):479-92. doi:10.1007/s00213-011-2595-7.

Agomelatine (S20098) modulates the expression of cytoskeletal microtubular proteins, synaptic markers and BDNF in the rat hippocampus, amygdala and PFC.

Ladurelle N, Gabriel C, Viggiano A, et al. Agomelatine (S20098) modulates the expression of cytoskeletal microtubular proteins, synaptic markers and BDNF in the rat hippocampus, amygdala and PFC. Psychopharmacology (Berl). 2012;221(3):493-509. doi:10.1007/s00213-011-2597-5.

Erratum to: Transition to drug addiction: a negative reinforcement model based on an allostatic decrease in reward function

Ahmed SH, Koob GF. Erratum to: Transition to drug addiction: a negative reinforcement model based on an allostatic decrease in reward function. Psychopharmacology. 2012;220(1):247 - 247. doi:10.1007/s00213-011-2591-y.

Quinpirole elicits differential in vivo changes in the pre- and postsynaptic distributions of dopamine D₂ receptors in mouse striatum: relation to cannabinoid-1 (CB₁) receptor targeting.

Lane DA, Chan J, Fitzgerald ML, et al. Quinpirole elicits differential in vivo changes in the pre- and postsynaptic distributions of dopamine D₂ receptors in mouse striatum: relation to cannabinoid-1 (CB₁) receptor targeting. Psychopharmacology (Berl). 2012;221(1):101-13. doi:10.1007/s00213-011-2553-4.

Lateralized hippocampal effects of vasoactive intestinal peptide on learning and memory in rats in a model of depression.

Ivanova M, Belcheva S, Belcheva I, Negrev N, Tashev R. Lateralized hippocampal effects of vasoactive intestinal peptide on learning and memory in rats in a model of depression. Psychopharmacology (Berl). 2012;221(4):561-74. doi:10.1007/s00213-011-2600-1.

Involvement of metabotropic glutamate receptor 5 in brain reward deficits associated with cocaine and nicotine withdrawal and somatic signs of nicotine withdrawal.

Stoker AK, Olivier B, Markou A. Involvement of metabotropic glutamate receptor 5 in brain reward deficits associated with cocaine and nicotine withdrawal and somatic signs of nicotine withdrawal. Psychopharmacology (Berl). 2012;221(2):317-27. doi:10.1007/s00213-011-2578-8.

In vivo electrophysiological and neurochemical effects of the selective 5-HT1A receptor agonist, F13640, at pre- and postsynaptic 5-HT1A receptors in the rat.

Lladó-Pelfort L, Assié M-B, Newman-Tancredi A, Artigas F, Celada P. In vivo electrophysiological and neurochemical effects of the selective 5-HT1A receptor agonist, F13640, at pre- and postsynaptic 5-HT1A receptors in the rat. Psychopharmacology (Berl). 2012;221(2):261-72. doi:10.1007/s00213-011-2569-9.

Examination of a role for metabotropic glutamate receptor 5 in the medial prefrontal cortex in cocaine sensitization in rats.

Timmer KM, Steketee JD. Examination of a role for metabotropic glutamate receptor 5 in the medial prefrontal cortex in cocaine sensitization in rats. Psychopharmacology (Berl). 2012;221(1):91-100. doi:10.1007/s00213-011-2548-1.

Effect of PDE10A inhibitors on MK-801-induced immobility in the forced swim test.

Langen B, Dost R, Egerland U, Stange H, Hoefgen N. Effect of PDE10A inhibitors on MK-801-induced immobility in the forced swim test. Psychopharmacology (Berl). 2012;221(2):249-59. doi:10.1007/s00213-011-2567-y.